Baidu
map

肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

2020 AIOM指南：早期结肠癌患者的管理

2020-12-01 意大利肿瘤医学协会 ESMO Open . 2020 Dec;5(6):e001001.

结肠癌

2020年12月，意大利肿瘤医学协会(AIOM)发布了早期结肠癌患者的管理指南。约有75%的结肠癌患者被诊断为早期癌症，可行根治性手术。本文主要针对早期结肠癌患者的管理提供指导建议，内容涉及筛查，诊断

中文标题：

2020 AIOM指南：早期结肠癌患者的管理

英文标题：

Management of patients with early-stage colon cancer: guidelines of the Italian Medical Oncology Association

发布机构：

意大利肿瘤医学协会

发布日期：

2020-12-01

简要介绍：

2020年12月，意大利肿瘤医学协会(AIOM)发布了早期结肠癌患者的管理指南。约有75%的结肠癌患者被诊断为早期癌症，可行根治性手术。本文主要针对早期结肠癌患者的管理提供指导建议，内容涉及筛查，诊断，治疗随访等。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 AIOM指南：早期结肠癌患者的管理.pdf)] GetToolGuiderByIdResponse(projectId=1, id=ee2611c002020e26, title=2020 AIOM指南：早期结肠癌患者的管理, enTitle=Management of patients with early-stage colon cancer: guidelines of the Italian Medical Oncology Association, guiderFrom=ESMO Open . 2020 Dec;5(6):e001001., authorId=0, author=, summary=2020年12月，意大利肿瘤医学协会(AIOM)发布了早期结肠癌患者的管理指南。约有75%的结肠癌患者被诊断为早期癌症，可行根治性手术。本文主要针对早期结肠癌患者的管理提供指导建议，内容涉及筛查，诊断, cover=https://img.medsci.cn/2020126/1607184194324_2020535.jpg, journalId=0, articlesId=null, associationId=1673, associationName=意大利肿瘤医学协会, associationIntro=, copyright=0, guiderPublishedTime=Tue Dec 01 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年12月，意大利肿瘤医学协会(AIOM)发布了早期结肠癌患者的管理指南。约有75%的结肠癌患者被诊断为早期癌症，可行根治性手术。本文主要针对早期结肠癌患者的管理提供指导建议，内容涉及筛查，诊断，治疗随访等。</p> </div> </div> </div>, tagList=[TagDto(tagId=249, tagName=结肠癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=76, categoryName=胃肠外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=249, guiderKeyword=结肠癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7309, appHits=240, showAppHits=0, pcHits=963, showPcHits=7069, likes=2, shares=22, comments=9, approvalStatus=1, publishedTime=Sun Dec 06 00:50:34 CST 2020, publishedTimeString=2020-12-01, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sun Dec 06 00:03:23 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 14:53:34 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 AIOM指南：早期结肠癌患者的管理.pdf)])
2020 AIOM指南：早期结肠癌患者的管理.pdf
下载请点击：
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1011975, encodeId=4b2110119e5f5, content=<a href='/topic/show?id=3263e877271' target=_blank style='color:#2F92EE;'>#结肠癌#</a>学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78772, encryptionId=3263e877271, topicName=结肠癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210825/82700696463c4ff6af4c47e83d972052/cf0751d6c499464a9193b553f89ce894.jpg, createdBy=881d5584286, createdName=贝宝聂是念来过倒5, createdTime=Fri Aug 27 10:17:32 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974948, encodeId=8b999e4948da, content=挺好的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fbd15219671, createdName=14778e28m54暂无昵称, createdTime=Sat Jun 19 19:41:34 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911399, encodeId=ac8091139989, content=早期结肠癌患者的管理, beContent=null, objectType=guider, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Sun Dec 27 21:07:01 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917404, encodeId=7cf991e4041a, content=从筛查治疗到随访内容全面。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4b35447270, createdName=ms4000000206232216, createdTime=Sun Jan 17 11:39:04 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909297, encodeId=9ec890929efb, content=全面, beContent=null, objectType=guider, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201209/33aadfc37c8048cdbc1a0e3e0d9fe2eb/a8bad71d7a764b78b26f5afd7bc5772f.jpg, createdBy=87c24011672, createdName=医路有感, createdTime=Sat Dec 19 08:13:53 CST 2020, time=2020-12-19, status=1, ipAttribution=)]
    2021-08-27 贝宝聂是念来过倒5

    #结肠癌#学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1011975, encodeId=4b2110119e5f5, content=<a href='/topic/show?id=3263e877271' target=_blank style='color:#2F92EE;'>#结肠癌#</a>学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78772, encryptionId=3263e877271, topicName=结肠癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210825/82700696463c4ff6af4c47e83d972052/cf0751d6c499464a9193b553f89ce894.jpg, createdBy=881d5584286, createdName=贝宝聂是念来过倒5, createdTime=Fri Aug 27 10:17:32 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974948, encodeId=8b999e4948da, content=挺好的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fbd15219671, createdName=14778e28m54暂无昵称, createdTime=Sat Jun 19 19:41:34 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911399, encodeId=ac8091139989, content=早期结肠癌患者的管理, beContent=null, objectType=guider, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Sun Dec 27 21:07:01 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917404, encodeId=7cf991e4041a, content=从筛查治疗到随访内容全面。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4b35447270, createdName=ms4000000206232216, createdTime=Sun Jan 17 11:39:04 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909297, encodeId=9ec890929efb, content=全面, beContent=null, objectType=guider, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201209/33aadfc37c8048cdbc1a0e3e0d9fe2eb/a8bad71d7a764b78b26f5afd7bc5772f.jpg, createdBy=87c24011672, createdName=医路有感, createdTime=Sat Dec 19 08:13:53 CST 2020, time=2020-12-19, status=1, ipAttribution=)]
    2021-06-19 14778e28m54暂无昵称

    挺好的

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1011975, encodeId=4b2110119e5f5, content=<a href='/topic/show?id=3263e877271' target=_blank style='color:#2F92EE;'>#结肠癌#</a>学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78772, encryptionId=3263e877271, topicName=结肠癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210825/82700696463c4ff6af4c47e83d972052/cf0751d6c499464a9193b553f89ce894.jpg, createdBy=881d5584286, createdName=贝宝聂是念来过倒5, createdTime=Fri Aug 27 10:17:32 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974948, encodeId=8b999e4948da, content=挺好的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fbd15219671, createdName=14778e28m54暂无昵称, createdTime=Sat Jun 19 19:41:34 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911399, encodeId=ac8091139989, content=早期结肠癌患者的管理, beContent=null, objectType=guider, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Sun Dec 27 21:07:01 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917404, encodeId=7cf991e4041a, content=从筛查治疗到随访内容全面。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4b35447270, createdName=ms4000000206232216, createdTime=Sun Jan 17 11:39:04 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909297, encodeId=9ec890929efb, content=全面, beContent=null, objectType=guider, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201209/33aadfc37c8048cdbc1a0e3e0d9fe2eb/a8bad71d7a764b78b26f5afd7bc5772f.jpg, createdBy=87c24011672, createdName=医路有感, createdTime=Sat Dec 19 08:13:53 CST 2020, time=2020-12-19, status=1, ipAttribution=)]
    2020-12-27 oo902

    早期结肠癌患者的管理

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1011975, encodeId=4b2110119e5f5, content=<a href='/topic/show?id=3263e877271' target=_blank style='color:#2F92EE;'>#结肠癌#</a>学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78772, encryptionId=3263e877271, topicName=结肠癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210825/82700696463c4ff6af4c47e83d972052/cf0751d6c499464a9193b553f89ce894.jpg, createdBy=881d5584286, createdName=贝宝聂是念来过倒5, createdTime=Fri Aug 27 10:17:32 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974948, encodeId=8b999e4948da, content=挺好的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fbd15219671, createdName=14778e28m54暂无昵称, createdTime=Sat Jun 19 19:41:34 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911399, encodeId=ac8091139989, content=早期结肠癌患者的管理, beContent=null, objectType=guider, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Sun Dec 27 21:07:01 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917404, encodeId=7cf991e4041a, content=从筛查治疗到随访内容全面。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4b35447270, createdName=ms4000000206232216, createdTime=Sun Jan 17 11:39:04 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909297, encodeId=9ec890929efb, content=全面, beContent=null, objectType=guider, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201209/33aadfc37c8048cdbc1a0e3e0d9fe2eb/a8bad71d7a764b78b26f5afd7bc5772f.jpg, createdBy=87c24011672, createdName=医路有感, createdTime=Sat Dec 19 08:13:53 CST 2020, time=2020-12-19, status=1, ipAttribution=)]
    2021-01-17 ms4000000206232216

    从筛查治疗到随访内容全面。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1011975, encodeId=4b2110119e5f5, content=<a href='/topic/show?id=3263e877271' target=_blank style='color:#2F92EE;'>#结肠癌#</a>学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=192, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78772, encryptionId=3263e877271, topicName=结肠癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210825/82700696463c4ff6af4c47e83d972052/cf0751d6c499464a9193b553f89ce894.jpg, createdBy=881d5584286, createdName=贝宝聂是念来过倒5, createdTime=Fri Aug 27 10:17:32 CST 2021, time=2021-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974948, encodeId=8b999e4948da, content=挺好的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fbd15219671, createdName=14778e28m54暂无昵称, createdTime=Sat Jun 19 19:41:34 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=911399, encodeId=ac8091139989, content=早期结肠癌患者的管理, beContent=null, objectType=guider, channel=null, level=null, likeNumber=154, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a37a1710612, createdName=oo902, createdTime=Sun Dec 27 21:07:01 CST 2020, time=2020-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917404, encodeId=7cf991e4041a, content=从筛查治疗到随访内容全面。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=153, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c4b35447270, createdName=ms4000000206232216, createdTime=Sun Jan 17 11:39:04 CST 2021, time=2021-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909297, encodeId=9ec890929efb, content=全面, beContent=null, objectType=guider, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201209/33aadfc37c8048cdbc1a0e3e0d9fe2eb/a8bad71d7a764b78b26f5afd7bc5772f.jpg, createdBy=87c24011672, createdName=医路有感, createdTime=Sat Dec 19 08:13:53 CST 2020, time=2020-12-19, status=1, ipAttribution=)]
    2020-12-19 医路有感

    全面

    0

相关指南

2019 ASCO临床实践指南：含奥沙利铂辅助治疗III期结肠癌的持续时间

美国临床肿瘤学会(ASCO,American Society of Clinical Oncology) · 2019-04-15

WSES指南：结肠癌和直肠癌急症-梗阻和穿孔

世界急诊外科学会(WSES,World Society of Emergency Surgery) · 2018-08-13

拓展阅读

ESMO临床实践指南：原发性结肠癌

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2010-10-05

2010 WSES 左侧梗阻性结肠癌管理指南

世界急诊外科学会(WSES,World Society of Emergency Surgery) · 2010-12-28

结肠癌规范化诊疗指南

中华人民共和国卫生部(MINISTRY OF HEALTH OF THE PEOPLE`S REPUBLIC OF CHINA) · 2013-04-23

2013 N-ECCO 欧洲克罗恩及溃疡性结肠癌患者护理共识声明

欧洲克罗恩病和结肠炎组织(ECCO,European Cron&#039;s and Colitis Organisation) · 2013-11-01

2017 ACPGBI指南：结肠癌，直肠癌以及肛门癌的管理

暂未更新 · 2017-06-20

WSES指南：结肠癌和直肠癌急症-梗阻和穿孔

世界急诊外科学会(WSES,World Society of Emergency Surgery) · 2018-08-13

Baidu
map
Baidu
map
Baidu
map